Milestone Pharmaceuticals Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2018 | — | — | $13.2M |
| Jun 2018 | — | — | $17.8M |
| Sep 2018 | — | — | $4.2M |
| Dec 2018 | — | $83.5M | $85.9M |
| Mar 2019 | $0 | $73.3M | $71.2M |
| Jun 2019 | $0 | $145.3M | $110.8M |
| Sep 2019 | $0 | $132.8M | $106.5M |
| Dec 2019 | $0 | $114.9M | $119.8M |
| Mar 2020 | — | $99.6M | $101.8M |
| Jun 2020 | — | $88.0M | $53.4M |
| Sep 2020 | — | $102.2M | $46.9M |
| Dec 2020 | — | $143.1M | $72.3M |
| Mar 2021 | — | $132.0M | $71.9M |
| Jun 2021 | — | $139.6M | $97.8M |
| Sep 2021 | — | $127.4M | $111.4M |
| Dec 2021 | — | $112.6M | $114.1M |
| Mar 2022 | — | $100.8M | $92.2M |
| Jun 2022 | — | $86.7M | $63.2M |
| Sep 2022 | — | $77.2M | $37.3M |
| Dec 2022 | — | $66.3M | $7.6M |
| Mar 2023 | $47.3M | $53.9M | $74.0M |
| Jun 2023 | $48.1M | $40.4M | $32.6M |
| Sep 2023 | $48.9M | $28.5M | $9.9M |
| Dec 2023 | $49.8M | $16.8M | $13.8M |
| Mar 2024 | $50.6M | $39.9M | $10.1M |
| Jun 2024 | $51.5M | $32.0M | $13.3M |
| Sep 2024 | $52.4M | $24.0M | $12.8M |
| Dec 2024 | $53.4M | $13.1M | $25.3M |
| Mar 2025 | $54.3M | $-6.1M | $45.1M |
| Jun 2025 | $55.2M | $-17.7M | $42.5M |
| Sep 2025 | $56.2M | $20.5M | $46.7M |
| Dec 2025 | $57.2M | $41.8M | $73.0M |
| Mar 2026 | $58.2M | $36.0M | $71.3M |
| Jun 2026 | $59.2M | $18.2M | $169.7M |